Financial Gravity Asset Management, Inc. Horizon Therapeutics Public LTD CO Transaction History

Financial Gravity Asset Management, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	SELL	$96.34 - $112.38 $578 - $674	-6 Reduced 5.5%	103 $965,000
Q1 2023 May 12, 2023	SELL	$107.32 - $113.5 $536 - $567	-5 Reduced 4.39%	109 $333,000
Q4 2022 Feb 15, 2023	SELL	$62.39 - $113.8 $27,701 - $50,527	-444 Reduced 79.57%	114 $17.2 Million
Q3 2022 Nov 03, 2022	SELL	$58.92 - $84.67 $9,545 - $13,716	-162 Reduced 22.5%	558 $201,000
Q2 2022 Aug 05, 2022	SELL	$79.4 - $116.36 $9,528 - $13,963	-120 Reduced 14.29%	720 $259,000
Q1 2022 May 13, 2022	SELL	$86.42 - $109.81 $11,407 - $14,494	-132 Reduced 13.58%	840 $339,000
Q4 2021 Feb 11, 2022	BUY	$98.56 - $119.91 $95,504 - $116,192	969 Added 32300.0%	972 $353,000
Q3 2021 Nov 12, 2021	BUY	$91.91 - $110.37 $275 - $331	3 New	3 $110,000
Q4 2019 Feb 28, 2020	SELL	$25.43 - $36.67 $406 - $586	-16 Closed	0 $0
Q3 2019 Oct 15, 2019	BUY	$23.0 - $27.97 $46 - $55	2 Added 14.29%	16 $0
Q2 2019 Jul 26, 2019	BUY	$22.81 - $28.48 $319 - $398	14 New	14 $0

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.